Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas

Journal of Investigative Dermatology

Volumn 132, Issue 4, 2012, Pages 1239-1246

  Fujimura, Taku ^a,b   Ring, Sabine ^a   Umansky, Viktor ^c   Mahnke, Karsten ^a   Enk, Alexander H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; NITRIC OXIDE SYNTHASE; PROGRAMMED DEATH 1 LIGAND 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; DOWN REGULATION; IMMUNOSUPPRESSIVE TREATMENT; MELANOMA; MOUSE; MYELOID DERIVED SUPRRESSOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; T CELL DEPLETION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

EID: 84858276057     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.416     Document Type: Article

References (31)

1. Bedke T, Pretsch L, Karakhanova S et al. (2010) Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: Involvement of programmed death-1 and IL-10. J Immunol 184:5562-70
2. Bronte V, Serafini P, Mazzoni A et al. (2003) -Arginine metabolism in myeloid cell controls T-lymphocyte functions. Trends Immunol 24:302-5
3. Cheng P, Corzo CA, Luetteke N et al. (2008) Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 205:2235-49
4. Curiel TJ, Cheng P, Mottram P et al. (2004) Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res 64:5535-8
5. Curiel TJ, Wei S, Dong H et al. (2003) Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9:562-7
6. Dugast AS, Haudebourg T, Coulon F et al. (2008) Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion. J Immunol 180:7898-905
7. Fujimura T, Mahnke K, Enk AH (2010) Myeloid derived suppressor cells and their role in tolerance induction in cancer. J Dermatol Sci 59:1-5
8. Fujimura T, Nakagawa S, Ohtani T et al. (2006) Inhibitory effect of the polyinosinic-polycytidylic acid/cationic liposome on the progression of murine B16F10 melanoma. Eur J Immunol 36:3371-80
9. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162-74
10. Gallina G, Dolcetti L, Serafini P et al. (2006) Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 116:2777-90
11. Hino R, Kabashima K, Kato Y et al. (2010) Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma. Cancer 116:1757-65
12. Huang B, Pan PY, Li Q et al. (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 66:1123-31
13. Johnson TS, Mahnke K, Storn V et al. (2008) Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 singlechain fragment variable molecule. Clin Cancer Res 14:8169-77
14. Keir ME, Francisco LM, Sharpe AH (2007) PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 19:309-14
15. Kimpfler S, Sevko A, Ring S et al. (2009) Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. J Immunol 183:6330-7
16. Kryczek I, Wei S, Zhu G et al. (2007) Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 67:8900-5
17. Kuipers H, Muskens F, Willart M et al. (2006) Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur J Immunol 36:2472-82
18. Mahnke K, Guo M, Lee S et al. (2000) The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 151:673-84
19. Mahnke K, Ring S, Johnson TS et al. (2007) Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: Role of B7-H3 expression and antigen presentation. Eur J Immunol 37:2117-25
20. Nausch N, Galani IE, Schlecker E et al. (2008) Mononuclear myeloid-derived ''suppressor'' cells express RAE-1 and activate natural killer cells. Blood 112:4080-9
21. Ostrand-Rosenberg S, Sinha P (2009) Myeloid-derived suppressor cells: Linking inflammation and cancer. J Immunol 182:4499-505
22. Rodriguez PC, Ernstoff MS, Hernandez C et al. (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpoplation of activated granulocytes. Cancer Res 69:1553-60
23. Schmid MC, Varner JA (2010) Myeloid cells in the tumor microenvironment: Modulation of tumor angiogenesis and tumor inflammation. J Oncol; e-pub ahead of print 16 May 2010
24. Serafini P, Mgebroff S, Noonan K et al. (2008) Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res 68:5439-49
25. Sica A, Bronte V (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117:1155-65
26. Sinha P, Clements VK, Bunt SK et al. (2007) Cross-talk between myeloidderived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 179:977-83
27. Viguier M, Lemaître F, Verola O et al. (2004) Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173:1444-53
28. Whiteside TL (2010) Immune responses to malignancies. J Allergy Clin Immunol 125(2 Suppl 2):S272-83
29. Yi KH, Chen L (2009) Fine tuning the immune response through B7-H3 and B7-H4. Immunol Rev 229:145-51
30. Youn JI, Nagaraj S, Collazo M et al. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 81:5791-802
31. Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263-74